AI-generated summary
This secondary analysis of a double-blind trial in people with major depressive disorder compared near-infrared transcranial photobiomodulation with sham treatment for sexual dysfunction. The authors report that the near-infrared group had a greater improvement in sexual function scores than the sham group, though the study was exploratory with a small sample.
- Participants
- 20
- Who or what was studied
- Individuals with major depressive disorder enrolled in a double-blind clinical trial of transcranial photobiomodulation
- Limits stated in the abstract
- The authors describe the study as exploratory with a small sample size, and the analysis was secondary to a trial designed for depression.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on doi.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Near-infrared, Transcranial photobiomodulation, Sham, Sample size. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.